The metabolites of oxprenolol (Trasicor) in man.

Suppr

超能文献

作者信息

Riess W, Huerzeler H, Raschdorf F

出版信息

Xenobiotica. 1974 Jun;4(6):365-73. doi: 10.3109/00498257409052112.

DOI:10.3109/00498257409052112

PMID:4842016

Abstract

摘要

相似文献

The metabolites of oxprenolol (Trasicor) in man.

Xenobiotica. 1974 Jun;4(6):365-73. doi: 10.3109/00498257409052112.

The metabolism of tinidazole in the rat and dog.替硝唑在大鼠和犬体内的代谢

Xenobiotica. 1973 Dec;3(12):801-12. doi: 10.3109/00498257309151604.

The metabolism in vivo 4,16-androstadien-3-one in man. Occurrence of 16-dehydro C 19 steroids, androstane-3,16,17-triols and other metabolites in urine.

Steroids Lipids Res. 1972;3(5):263-85.

N-methylation, a newly identified pathway in the dog for the metabolism of oxprenolol, a beta-receptor blocking agent.

Drug Metab Dispos. 1973 May-Jun;1(3):565-8.

Metabolism of orphenadrine citrate in man.

J Pharmacol Exp Ther. 1971 Feb;176(2):284-95.

Studies on the intestinal absorption and metabolism of phytylubiquinone-(1',2'- 3 H) (hexahydroubiquinone-4) in man.

Int J Vitam Nutr Res. 1971;41(2):189-203.

Disposition of human drug preparations in the horse. V. Orally administered oxprenolol.

Biomed Chromatogr. 1996 Jul-Aug;10(4):172-8. doi: 10.1002/(SICI)1099-0801(199607)10:4<172::AID-BMC588>3.0.CO;2-1.

Metabolism of intravenously administered 17-beta-estradiol-6,7-3H-3-glucoside-14C in normal women.

J Clin Endocrinol Metab. 1971 Apr;32(4):476-80. doi: 10.1210/jcem-32-4-476.

Distribution, biotransformation and excretion of bupivacaine in the rat and the monkey.

Xenobiotica. 1973 Dec;3(12):761-72. doi: 10.3109/00498257309151601.

Metabolism of iophenoxic acid in the dog.

J Pharmacol Exp Ther. 1971 Jul;178(1):173-9.

引用本文的文献

Extracorporeal treatment for poisoning to beta-adrenergic antagonists: systematic review and recommendations from the EXTRIP workgroup.体外治疗β-肾上腺素能拮抗剂中毒：EXTRIP 工作组的系统评价和建议。

Crit Care. 2021 Jun 10;25(1):201. doi: 10.1186/s13054-021-03585-7.

Antihypertensive drugs metabolism: an update to pharmacokinetic profiles and computational approaches.抗高血压药物代谢：药代动力学特征与计算方法的最新进展

Curr Pharm Des. 2015;21(6):806-22. doi: 10.2174/1381612820666141024151119.

Bioavailability of beta-adrenoceptor blocking drugs.β-肾上腺素受体阻断药的生物利用度。

Br J Clin Pharmacol. 1976 Dec;3(6):1064-5; author reply 1066. doi: 10.1111/j.1365-2125.1976.tb00361.x.

Prediction of metabolic drug interactions involving beta-adrenoceptor blocking drugs.涉及β-肾上腺素能受体阻断药物的代谢性药物相互作用预测

Br J Clin Pharmacol. 1984;17 Suppl 1(Suppl 1):3S-10S. doi: 10.1111/j.1365-2125.1984.tb02422.x.

Pharmacokinetics and metabolism of a new beta-adrenergic blocking agent, the 1, ter-butyl-amino-3-(1,2,3,4-tetrahydro-1,4-ethano-8-hydroxy-5-naphthoxy)-2-propanol (K 5407).一种新型β-肾上腺素能阻滞剂1-叔丁基氨基-3-（1,2,3,4-四氢-1,4-亚乙基-8-羟基-5-萘氧基）-2-丙醇（K 5407）的药代动力学和代谢

Eur J Drug Metab Pharmacokinet. 1980;5(1):9-20. doi: 10.1007/BF03189437.

Polymorphic metabolism of the beta-adrenoreceptor blocking drugs and its clinical relevance.β-肾上腺素能受体阻断药物的多态性代谢及其临床意义。

Eur J Clin Pharmacol. 1985;28 Suppl:77-84. doi: 10.1007/BF00543715.

Trial of combination of guanethidine and oxprenolol in hypertension.胍乙啶与氧烯洛尔联合治疗高血压的试验

Br Med J. 1976 Apr 17;1(6015):933-6. doi: 10.1136/bmj.1.6015.933.

Effects of inflammatory disease on plasma oxprenolol concentrations.

Br Med J. 1979 Aug 25;2(6188):465-8. doi: 10.1136/bmj.2.6188.465.

Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs.β-肾上腺素受体阻断药的临床药代动力学

Clin Pharmacokinet. 1976;1(4):233-63. doi: 10.2165/00003088-197601040-00001.

Hypertension: which beta-blocker?高血压：选用哪种β受体阻滞剂？

Drugs. 1976 Dec;12(6):412-14. doi: 10.2165/00003495-197612060-00002.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验